Payment overview · 2025
General Payments
$146.09
5 reported records · 3 companies
Healthcare provider profile · identity verified
Jorge C Martinez, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · COAMO, PR · NPI 1225132772
Verified facts
What the public records show
CMS Open Payments records show Jorge C Martinez, M.D. received $146.09 in general payments during 2025 across 5 reported records.
Medtronic, Inc. accounted for 66.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis.
PBG PUERTO RICO LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 738 records involving 435 distinct recipient NPIs. Public Medicare Part D data also shows 70 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$97.36 | 66.6% | 3 | 2025 |
| Eli Lilly Export S.A. Puerto Rico Branch | Unresolved — no canonical attribution shown | $25.00 | 17.1% | 1 | 2025 |
| PBG PUERTO RICO LLC | Unresolved — no canonical attribution shown | $23.73 | 16.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $146.09 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ENDURANT IIS Normalized: endurant iis |
Device | Medtronic, Inc. | $97.36 | 3 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Eli Lilly Export S.A. Puerto Rico Branch | $25.00 | 1 | 2025 |
Source payment records
|
|||||
| ELIQUIS Normalized: eliquis |
Drug | PBG PUERTO RICO LLC | $23.73 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 70 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| PBG PUERTO RICO LLC Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 738 supporting records · 435 recipient NPIs · example record 1228798592 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
70 | 23 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1102 | 260 |
| Gabapentin | Gabapentin | 816 | 141 |
| Famotidine | Famotidine | 752 | 138 |
| Simvastatin | Simvastatin | 684 | 128 |
| Pantoprazole Sodium | Pantoprazole Sodium | 576 | 122 |
| Synthroid | Levothyroxine Sodium | 572 | 95 |
| Lisinopril | Lisinopril | 489 | 90 |
| Omeprazole | Omeprazole | 477 | 73 |
| Losartan Potassium | Losartan Potassium | 471 | 113 |
| Metformin Hcl | Metformin Hcl | 468 | 90 |
| Levothyroxine Sodium | Levothyroxine Sodium | 405 | 73 |
| Amlodipine Besylate | Amlodipine Besylate | 379 | 77 |
| Tamsulosin Hcl | Tamsulosin Hcl | 266 | 48 |
| Furosemide | Furosemide | 253 | 79 |
| Hydralazine Hcl | Hydralazine Hcl | 243 | 53 |
| Hydrochlorothiazide | Hydrochlorothiazide | 239 | 50 |
| Clopidogrel | Clopidogrel Bisulfate | 225 | 53 |
| Metoprolol Tartrate | Metoprolol Tartrate | 219 | 53 |
| Glipizide | Glipizide | 201 | 37 |
| Carvedilol | Carvedilol | 174 | 46 |
| Metoprolol Succinate | Metoprolol Succinate | 166 | 50 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 164 | 36 |
| Allopurinol | Allopurinol | 158 | 32 |
| Tramadol Hcl | Tramadol Hcl | 158 | 45 |
| Clonazepam | Clonazepam | 151 | 40 |
| Montelukast Sodium | Montelukast Sodium | 135 | 29 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 132 | 24 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 132 | 21 |
| Enalapril Maleate | Enalapril Maleate | 131 | 23 |
| Meclizine Hcl | Meclizine Hcl | 129 | 40 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 128 | 56 |
| Nabumetone | Nabumetone | 128 | 39 |
| Glimepiride | Glimepiride | 126 | 28 |
| Gemfibrozil | Gemfibrozil | 110 | 30 |
| Latanoprost | Latanoprost | 109 | 20 |
| Dexamethasone | Dexamethasone | 107 | 86 |
| Alendronate Sodium | Alendronate Sodium | 104 | 19 |
| Cefadroxil | Cefadroxil | 103 | 93 |
| Fenofibrate | Fenofibrate | 100 | 25 |
| Lansoprazole | Lansoprazole | 99 | 17 |
| Donepezil Hcl | Donepezil Hcl | 93 | 24 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 90 | 21 |
| Azithromycin | Azithromycin | 88 | 71 |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 86 | 16 |
| Finasteride | Finasteride | 85 | 17 |
| Naproxen | Naproxen | 83 | 35 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 83 | 11 |
| Nifedipine Er | Nifedipine | 79 | 24 |
| Alprazolam | Alprazolam | 77 | 14 |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 73 | 18 |
| Eliquis | Apixaban | 70 | 23 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 68 | 14 |
| Doxazosin Mesylate | Doxazosin Mesylate | 65 | 17 |
| Meloxicam | Meloxicam | 63 | 23 |
| Atenolol | Atenolol | 62 | 19 |
| Irbesartan | Irbesartan | 61 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 60 | 22 |
| Warfarin Sodium | Warfarin Sodium | 59 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 55 | suppressed |
| Brilinta | Ticagrelor | 54 | 18 |
| Cephalexin | Cephalexin | 52 | 48 |
| Prednisone | Prednisone | 50 | 26 |
| Zolpidem Tartrate | Zolpidem Tartrate | 50 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 49 | 32 |
| Breo Ellipta | Fluticasone/Vilanterol | 47 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 47 | 26 |
| Jentadueto | Linagliptin/Metformin Hcl | 47 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 47 | suppressed |
| Rivastigmine | Rivastigmine | 47 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 46 | suppressed |
| Spironolactone | Spironolactone | 45 | 21 |
| Sure Comfort | Syringe-Needle,insulin,0.5 Ml | 45 | 13 |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 44 | 15 |
| Ibuprofen | Ibuprofen | 42 | 18 |
| Sertraline Hcl | Sertraline Hcl | 42 | suppressed |
| Baclofen | Baclofen | 41 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 41 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 41 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 39 | 33 |
| Insulin Lispro | Insulin Lispro | 39 | 11 |
| Lamotrigine | Lamotrigine | 39 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 37 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 36 | 11 |
| Duloxetine Hcl | Duloxetine Hcl | 36 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 36 | 11 |
| Sure Comfort | Syringe And Needle,insulin,1ml | 35 | suppressed |
| Calcitriol | Calcitriol | 34 | suppressed |
| Ezetimibe | Ezetimibe | 34 | suppressed |
| Levofloxacin | Levofloxacin | 34 | 31 |
| Theophylline Er | Theophylline Anhydrous | 34 | suppressed |
| Tradjenta | Linagliptin | 33 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 31 | 13 |
| Memantine Hcl | Memantine Hcl | 31 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 31 | suppressed |
| Celecoxib | Celecoxib | 30 | suppressed |
| Humalog Mix 75-25 | Insulin Lispro Protamin/Lispro | 30 | suppressed |
| Levetiracetam | Levetiracetam | 30 | suppressed |
| Verapamil Er | Verapamil Hcl | 30 | suppressed |
| Jentadueto Xr | Linagliptin/Metformin Hcl | 29 | suppressed |
| Lorazepam | Lorazepam | 29 | suppressed |
| Ranolazine Er | Ranolazine | 29 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 28 | suppressed |
| Cilostazol | Cilostazol | 27 | suppressed |
| Digoxin | Digoxin | 27 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 26 | 11 |
| Glipizide Er | Glipizide | 26 | suppressed |
| Humalog | Insulin Lispro | 26 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 26 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 26 | 12 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 26 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 25 | 22 |
| Sulindac | Sulindac | 25 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 24 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 23 | suppressed |
| Loperamide | Loperamide Hcl | 23 | suppressed |
| Hydrocortisone | Hydrocortisone | 22 | 11 |
| Insulin Glargine | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Premarin | Estrogens, Conjugated | 22 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 22 | suppressed |
| Sure Comfort | Syring-Needl,disp,insul,0.3 Ml | 22 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 22 | 11 |
| Fluorometholone | Fluorometholone | 21 | suppressed |
| Ketoconazole | Ketoconazole | 21 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 21 | suppressed |
| Ramipril | Ramipril | 21 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 21 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 21 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 20 | suppressed |
| Orphenadrine Citrate | Orphenadrine Citrate | 20 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 19 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 19 | suppressed |
| Sucralfate | Sucralfate | 19 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 18 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Nitroglycerin | Nitroglycerin | 18 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 18 | suppressed |
| Temazepam | Temazepam | 18 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 17 | 14 |
| Captopril | Captopril | 17 | suppressed |
| Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Valsartan | Valsartan | 17 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 16 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 16 | 12 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 16 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 16 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 16 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 16 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 16 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 15 | 15 |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 15 | suppressed |
| Mirtazapine | Mirtazapine | 15 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 15 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 15 | suppressed |
| Diclofenac Sodium Er | Diclofenac Sodium | 14 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 14 | suppressed |
| Humalog Mix 50-50 Kwikpen | Insulin Lispro Protamin/Lispro | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | 13 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 13 | suppressed |
| Estazolam | Estazolam | 13 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Olanzapine | Olanzapine | 13 | suppressed |
| Trulicity | Dulaglutide | 13 | suppressed |
| Verapamil Er Pm | Verapamil Hcl | 13 | suppressed |
| Xarelto | Rivaroxaban | 13 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 12 | suppressed |
| Jardiance | Empagliflozin | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Pregabalin | Pregabalin | 12 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 12 | suppressed |
| Advocate Syringes | Syringe-Needle,insulin,0.5 Ml | 11 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 11 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 11 | suppressed |
| Entresto | Sacubitril/Valsartan | 11 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 11 | suppressed |
| Humulin R | Insulin Regular, Human | 11 | suppressed |
| Ibu | Ibuprofen | 11 | suppressed |
| Indapamide | Indapamide | 11 | suppressed |
| Methotrexate | Methotrexate Sodium | 11 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 11 | suppressed |
| Topamax | Topiramate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $146.09 · 5 records | Medtronic, Inc. | ELIQUIS, ENDURANT IIS, ZEPBOUND | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Eliquis play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with PBG PUERTO RICO LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error